Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington, DC 20001
E: [email protected]
Dr. Oluwakemi “Kemi” Odesina is a senior Labeling Reviewer in the Division of Labeling Review (DLR), Office of Regulatory Operations (ORO), within the Office of Generic Drugs (OGD).
She began her federal career in 2011 as an inpatient clinical pharmacist at the Walter Reed National Military Medical Center. She joined the Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) in 2014.
Dr. Odesina completed her undergraduate studies at the University of Maryland, College Park and earned her Doctor of Pharmacy degree (PharmD) at the University of Charleston School of Pharmacy. She is a Board-Certified Pharmacotherapy Specialist (BCPS). She is also Certified in Public Health (CPH).